Probi is a leader in probiotics, a promising, high-growth research segment with major potential.
The main R&D fields are gastrointestinal disorders, the immune system, metabolic disorders, and stress and performance recovery. The company’s bacteria strains are offered to licensees through its Functional Food and Dietary Supplements business areas. We offer our customers innovative, well documented and patented probiotic product concepts. Our offering has been the subject of major interest, and has attracted multinational corporations like Kraft, Danone and NextFoods as well as Institut Rosell, Merck and Metagenics. Product concepts include fruit drinks and shots, yoghurt and ice cream, soy, cereal and bars, tablets, capsules and sachets.
Present in 40 markets around the world
Probi’s headquarters are in Lund, Sweden. Key business partners in Functional Food are Skånemejerier and the US company NextFoods and important partners in Dietary Supplements are Institut Rosell, Merck & Co, Sanum Polska, Proton System and Health World/Metagenics in Australia and the US. Products containing Probi’s bacteria are marketed in more than 40 markets around the world.
|
